InnoPharm 2026: 2nd Edition of Innovations in Pharma R&D
Hosted by CO-IN Symposia LLC
- 2 – 4 November 2026
Add to calendar
Welcome to kongre.net - Holiday Inn Boston Hotel, Boston, United States of America
- Health SciencesPharmacy & Pharmaceutical Sciences
Let others know you'll be there. This does not register you for the event.
Registration
Registration is handled by the organiser
Fees are listed on this page
View registration detailsKey facts
InnoPharm 2026: 2nd Edition of Innovations in Pharma R&D is a conference held 2 – 4 November 2026 in Holiday Inn Boston Hotel, Boston, United States of America, organised by CO-IN Symposia LLC.
- Dates:
- 2 – 4 November 2026
- Format:
- Hybrid (in person and online)
- Venue:
- Holiday Inn Boston Hotel, Boston, United States of America
- Subjects:
- Pharmacy & Pharmaceutical Sciences
- Organiser:
- CO-IN Symposia LLC
- Official website:
- pharm-science.com
InnoPharm 2026 is the second edition of the Innovations in Pharma R&D conference, organized by CO-IN Symposia. Taking place from November 2-4, 2026, in Boston, MA, the event brings together leading researchers, industry experts, and emerging innovators for a three-day journey focusing on breakthroughs, collaborations, and technologies driving the next era of global healthcare. The conference features specialized tracks, interactive sessions, and networking opportunities designed to unite academia, industry, and regulatory experts.
Conference theme
Topics
Who should attend
Organising Committee
- CO-IN Symposia Organizing Team
Scientific Committee
- Prof. Debbie C. Crans, Colorado State University
- Prof. Ruben Abagyan, University of California, San Diego, USA
- Dr. Girish Nallur, Vistara Bioscience, USA
- Dr. Urszula Komarnicka, University of Wrocław, Poland
Programme highlights
View full programmeKeynote speakers
View programmeKeynote
Professor, Dana-Farber Cancer Institute, Harvard Medical School
KAT6A/B Inhibitor Transcriptionally Upregulates GD2 to Sensitize Neuroblastoma Cells to Targeted ImmunotherapyKeynote
Professor, Stanford University
The SPARK Model of Translational Research in Academia; a 20 Years ReportKeynote
Professor, Colorado State University
Beyond the Active Species: Transformation Networks in Vanadium Pharmacology2 conferences on kongre.netKeynote
Founding Director & Core Faculty, Wyss Institute at Harvard University
Human Organ Chips for Disease Modeling, Drug Development, and Personalized MedicineKeynote
Professor, Virginia Polytechnic Institute & State University
Rejuvenation of Innate Immunity for Treating Chronic Inflammatory DiseaseKeynote
Professor, Brigham and Women’s Hospital, Harvard Medical School
Epigenetic Inhibitors as Novel Therapeutics: Applications in Cancer and Beyond
Speakers
View all 15 speakersDebbie C. CransKeynote
Colorado State University
Beyond the Active Species: Transformation Networks in Vanadium PharmacologyWyss Institute at Harvard University, Boston, MA
National Institute of Health, Rockville, MD
Donald IngberKeynote
Wyss Institute at Harvard University
Human Organ Chips for Disease Modeling, Drug Development, and Personalized MedicineLSU Health New Orleans, New Orleans, LA
Ludwig-Maximilians-Universität München, Germany
Rhoda AlaniKeynote
Brigham and Women’s Hospital, Harvard Medical School
Epigenetic Inhibitors as Novel Therapeutics: Applications in Cancer and Beyond
Organiser and contact
Contact
- Event secretary:
- Gayatri Srinivas
- Email:
- [email protected]
Advertisement
Related events
- 10th Dermatology Drug Development SummitBoston, United States of America3–5 Nov 2026
- 3rd ADC Payload SummitBoston, United States of America4–6 Nov 2026
- 11th Microbiome Movement USA SummitBoston, United States of America9–11 Nov 2026
- Protein Design & Engineering Summit 2026Boston, United States of America10–12 Nov 2026
- 9th RNA-Targeted Drug Discovery & Development SummitBoston, United States of America10–12 Nov 2026
- Biomarker Operations & Biospecimen Management SummitBoston, United States of America16–17 Nov 2026